Clinical Trials Logo

Clinical Trial Summary

Detection of subclinical enthesitis by ultrasonography


Clinical Trial Description

A total of 30 patients with psoriasis and 30 age-matched healthy controls, all without musculoskeletal diseases, will be recruited. They will undergo dermatological assessment and a blinded ultrasound (US) evaluation. Clinical assessment included demographics, severity of psoriasis and musculoskeletal clinical examination. Evaluation consisted of the detection of grey scale (GS) enthesitis and Power Doppler signal in enthesis areas. The Madrid Sonography Enthesitis Index (MASEI) scoring system was used to quantify the extent of sonographic entheseal abnormalities. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04209894
Study type Observational
Source Fatih Sultan Mehmet Training and Research Hospital
Contact
Status Completed
Phase
Start date September 15, 2021
Completion date March 15, 2023

See also
  Status Clinical Trial Phase
Completed NCT04946539 - Value of Ultrasonographic Enthesitis Assessment in Spondyloarthritis
Active, not recruiting NCT04887597 - EBIO - Enthesitis Biopsy Study Phase 4
Completed NCT05942976 - Enthesis Differences in Rheumatoid Arthritis and Axial Spondyloarthropathy
Completed NCT04953871 - Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis Phase 4
Completed NCT03955861 - Ultrasound Enthesitis Response in Psoriatic Arthritis
Not yet recruiting NCT04224597 - Evaluation of the Presence of Enthesitis in Patients With Acne Vulgaris
Completed NCT02771210 - Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site Phase 3
Recruiting NCT03248284 - Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons